Results 101 to 110 of about 13,977 (118)

Chemical Catalysis Guides Structural Identification for the Major In Vivo Metabolite of the BET Inhibitor JQ1 [PDF]

open access: yesACS Medicinal Chemistry Letters
The bromodomain inhibitor (+)-JQ1 is a highly validated chemical probe; however, it exhibits poor in vivo pharmacokinetics. To guide efforts toward improving its pharmacological properties, we identified the (+)-JQ1 primary metabolite using chemical ...
Kevin Mackenzie   +2 more
exaly   +2 more sources
Some of the next articles are maybe not open access.

Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment

International Journal of Molecular Sciences, 2022
Francesco Paolo Fiorentino   +2 more
exaly  

JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer

European Journal of Cancer, 2020
Michalis Liontos   +2 more
exaly  

BRD4 inhibition by JQ1 prevents high-fat diet-induced diabetic cardiomyopathy by activating PINK1/Parkin-mediated mitophagy in vivo

Journal of Molecular and Cellular Cardiology, 2020
Donghong Zhang   +2 more
exaly  

Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma

International Journal of Cancer, 2015
H Phillip Koeffler   +2 more
exaly  

Home - About - Disclaimer - Privacy